AAAAAA

   
Results: 1-10 |
Results: 10
Immobilization of eta(5)-cyclopentadienyltris(dimethylamido) zirconium polymerization catalysts on a chlorosilane- and HMDS-modified mesoporous silica surface: a new concept for supporting metallocene amides towards heterogeneous single-site-catalysts
Authors: Schneider, H Puchta, GT Kaul, FAR Raudaschl-Sieber, G Lefebvre, F Saggio, G Mihalios, D Herrmann, WA Basset, JM
Citation: H. Schneider et al., Immobilization of eta(5)-cyclopentadienyltris(dimethylamido) zirconium polymerization catalysts on a chlorosilane- and HMDS-modified mesoporous silica surface: a new concept for supporting metallocene amides towards heterogeneous single-site-catalysts, J MOL CAT A, 170(1-2), 2001, pp. 127-141
Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer
Authors: Recchia, F De Filippis, S Rosselli, M Saggio, G Cesta, A Fumagalli, L Rea, S
Citation: F. Recchia et al., Phase 1B study of subcutaneously administered interleukin 2 in combinationwith 13-cis retinoic acid as maintenance therapy in advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1251-1257
Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study
Authors: Recchia, F De Filippis, S Rosselli, M Saggio, G Carta, G Rea, S
Citation: F. Recchia et al., Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study, EUR J GYN O, 22(4), 2001, pp. 287-291
Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer
Authors: Recchia, F De Filippis, S Rosselli, M Saggio, G Pompili, P Piccinini, M Rea, S
Citation: F. Recchia et al., Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer, AM J CL ONC, 24(4), 2001, pp. 392-396
Ifosfamide, cisplatin, and 13-cis retinoic acid for patients with advancedor recurrent squamous cell carcinoma of the head and neck - A phase I-II study
Authors: Recchia, F Lalli, A Lombardo, M De Filippis, S Saggio, G Fabbri, F Rosselli, M Capomolla, E Rea, S
Citation: F. Recchia et al., Ifosfamide, cisplatin, and 13-cis retinoic acid for patients with advancedor recurrent squamous cell carcinoma of the head and neck - A phase I-II study, CANCER, 92(4), 2001, pp. 814-821
New reactions of C-C bond cleavage and formation catalysed by silica-supported tantalum and tungsten hydrides
Authors: Maury, O Saggio, G Theolier, AT Taoufik, M Vidal, V Thivolle-Cazat, J Basset, JM
Citation: O. Maury et al., New reactions of C-C bond cleavage and formation catalysed by silica-supported tantalum and tungsten hydrides, CR AC S IIC, 3(7), 2000, pp. 583-587
Broadband peaking techniques for HEMT-based monolithic transimpedance amplifiers
Authors: Giannini, F Limiti, E Orengo, G Saggio, G
Citation: F. Giannini et al., Broadband peaking techniques for HEMT-based monolithic transimpedance amplifiers, MICROW OPT, 24(3), 2000, pp. 147-151
Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study
Authors: Recchia, F Sica, G De Filippis, S Rosselli, M Saggio, G Guerriero, G Pompili, P Rea, S
Citation: F. Recchia et al., Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study, ANTICANC R, 20(3B), 2000, pp. 1985-1990
Experimental performances of 5GHz harmonic-manipulated high efficiency microwave power amplifiers
Authors: Colantonio, P Giannini, F Limiti, E Saggio, G
Citation: P. Colantonio et al., Experimental performances of 5GHz harmonic-manipulated high efficiency microwave power amplifiers, ELECTR LETT, 36(9), 2000, pp. 800-801
Chemo-immunotherapy in advanced head and neck cancer
Authors: Recchia, F Sica, G De Filippis, S Rosselli, M Pompili, P Saggio, G Rea, S
Citation: F. Recchia et al., Chemo-immunotherapy in advanced head and neck cancer, ANTICANC R, 19(1B), 1999, pp. 773-777
Risultati: 1-10 |